)
)
Oyster Point Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Oyster Point Pharma Inc
Access all reports
Oyster Point Pharma, Inc. is a biopharmaceutical company focused on developing therapies to address ophthalmic diseases. The company's primary area of focus is the treatment of dry eye disease and other ocular surface conditions. Oyster Point leverages its expertise in neuroscience and ophthalmology to develop innovative therapeutic solutions that aim to improve eye health and patient quality of life. The company serves the healthcare sector, specifically targeting the ophthalmology field with products designed to meet unmet medical needs in eye care. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
OYST
Country
🇺🇸 United States